This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Treatment

Authoring team

A variety of different drugs may be used in the treatment of spasticity including diazepam, baclofen and dantrolene sodium. All of these drugs result in muscle weakness.

Tizanidine is a relatively new drug used in the treatment of spasticity. It appears to be slightly better tolerated than other oral drugs (diazepam and baclofen). Also muscle weakness is less likely to occur than with treament with baclofen or diazepam (1).

There is no convincing evidence of a superior efficacy of any of the oral drug treatments (diazepam, baclofen, tizanidine) for spasticity (2).

Reference:

  • 1) Wallace JD (1994). Summary of combined analysis of controlled clinical trials with tizanidine. Neurology 44 (Suppl 9), s60-9.
  • 2) Drug and Therapeutics Bulletin (2000), 38 (6), 44-6.

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.